About Us

Founded in 2018, Rinri Therapeutics Ltd. is a therapeutic discovery and development company working in the field of hearing loss supported by Boehringer Ingelheim Venture Fund and UCB Ventures, BioCity and The University of Sheffield.

Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.

The Company has a team of experienced management, strong academic pedigree and excellent potential for clinical development.

Latest News

People

Nick Higgins

Independent Chair
Nick is an experienced life sciences executive with significant business and corporate development achievements. More

Dr. Erica Whittaker

Investor Director

Erica is Head of UCB Ventures, a strategic corporate venture fund, established in 2017 More

Frank Kalkbrenner

Investor Director

Frank is the Global Head of the Boehringer Ingelheim Venture Fund. More

Prof. Marcelo Rivolta

Founder Director

Marcelo is a globally recognised thought leader in the field of sensory stems cells authoring over 40 papers in the field including publishing in Nature. More

Dr. Simon Chandler

CEO

Simon has deep sector knowledge and in-depth experience of the biotech sector. More

Dr. Natalie Mount

Non-Executive Director

Natalie is currently the CEO of Adaptate Biotherapeutics . focused on developing therapeutic antibodies More

Dr. Terri Gaskell

CTO
Terri has over 20 years of life sciences R&D experience in both academic and industry roles. More

Dr. Faizah Mushtaq

Clinical Manager
Faizah is a clinically qualified audiologist who has previously provided hearing care to patients within both NHS and private settings. More